1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Peritonitis Global Clinical Trials Review, H1, 2015

Peritonitis Global Clinical Trials Review, H1, 2015

  • May 2015
  • -
  • Global Data
  • -
  • 72 pages

Peritonitis Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Peritonitis Global Clinical Trials Review, H1, 2015" provides an overview of Peritonitis clinical trials scenario. This report provides top line data relating to the clinical trials on Peritonitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Peritonitis Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Peritonitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Peritonitis to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Peritonitis to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Peritonitis 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Peritonitis Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Pfizer Inc. 32
Clinical Trial Overview of Pfizer Inc. 32
Johnson and Johnson 33
Clinical Trial Overview of Johnson and Johnson 33
Bayer AG 34
Clinical Trial Overview of Bayer AG 34
PRO-BIO Biotech. Co., Ltd 35
Clinical Trial Overview of PRO-BIO Biotech. Co., Ltd 35
Pharmaero ApS 36
Clinical Trial Overview of Pharmaero ApS 36
Otsuka Holdings Co., Ltd. 37
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 37
Jhaver Research Foundation Ltd 38
Clinical Trial Overview of Jhaver Research Foundation Ltd 38
Fujifilm Holdings Corporation 39
Clinical Trial Overview of Fujifilm Holdings Corporation 39
Daiichi Sankyo Company, Limited 40
Clinical Trial Overview of Daiichi Sankyo Company, Limited 40
Baxter International Inc. 41
Clinical Trial Overview of Baxter International Inc. 41
Clinical Trial Overview of Top Institutes / Government 42
University of Tartu 42
Clinical Trial Overview of University of Tartu 42
Aalborg University Hospital 43
Clinical Trial Overview of Aalborg University Hospital 43
Aditya Birla Memorial Hospital 44
Clinical Trial Overview of Aditya Birla Memorial Hospital 44
Albert-Ludwigs-Universitat Freiburg 45
Clinical Trial Overview of Albert-Ludwigs-Universitat Freiburg 45
All India Institute of Medical Sciences 46
Clinical Trial Overview of All India Institute of Medical Sciences 46
Assistance Publique - Hopitaux de Paris 47
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 47
Chang Gung Memorial Foundation 48
Clinical Trial Overview of Chang Gung Memorial Foundation 48
Chinese University of Hong Kong 49
Clinical Trial Overview of Chinese University of Hong Kong 49
Chulalongkorn University 50
Clinical Trial Overview of Chulalongkorn University 50
Cornell University 51
Clinical Trial Overview of Cornell University 51
Five Key Clinical Profiles 52
Appendix 70
Abbreviations 70
Definitions 70
Research Methodology 71
Secondary Research 71
About GlobalData 72
Contact Us 72
Disclaimer 72
Source 72

List of Tables
Peritonitis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Peritonitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Peritonitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Peritonitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Peritonitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Peritonitis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Peritonitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Peritonitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Peritonitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Peritonitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Peritonitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Peritonitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Peritonitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Peritonitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Peritonitis Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Peritonitis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Peritonitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Peritonitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Peritonitis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Peritonitis Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Peritonitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Peritonitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Peritonitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Peritonitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Peritonitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 32
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2015* 33
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 34
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by PRO-BIO Biotech. Co., Ltd, 2015* 35
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmaero ApS, 2015* 36
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015* 37
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Jhaver Research Foundation Ltd, 2015* 38
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Fujifilm Holdings Corporation, 2015* 39
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 40
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2015* 41
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Tartu, 2015* 42
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Aalborg University Hospital, 2015* 43
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Aditya Birla Memorial Hospital, 2015* 44
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Albert-Ludwigs-Universitat Freiburg, 2015* 45
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2015* 46
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 47
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chang Gung Memorial Foundation, 2015* 48
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015* 49
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chulalongkorn University, 2015* 50
Peritonitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cornell University, 2015* 51

List of Figures
Peritonitis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Peritonitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Peritonitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Peritonitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Peritonitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Peritonitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Peritonitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Peritonitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Peritonitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Peritonitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Peritonitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Peritonitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Peritonitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Peritonitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Peritonitis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Peritonitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Peritonitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Peritonitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Peritonitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Peritonitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Peritonitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Peritonitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Peritonitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 71

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.